Four drug combination helps in lung cancer: U.S. study
WASHINGTON (Reuters) - Combining two chemotherapy drugs with two targeted therapies was safe and appeared to help patients with advanced lung cancer live longer, U.S. researchers reported on Thursday.</p><div class="feedflare">
<img src="http://feedproxy.google.com/~f/reuters/healthNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=4p1iz3qG) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=nXqJyG3v" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=nXqJyG3v) <img src="http://feedproxy.google.com/~f/reuters/healthNews?i=th61Odpy" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=th61Odpy)
</div><img src="http://feedproxy.google.com/~r/reuters/healthNews/~4/VbZppZS0PBA" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/VbZppZS0PBA/idUSTRE4AC6OI20081113